Universe Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 1.86
| UPC Stock | USD 1.86 0.07 3.63% |
Universe |
Universe Pharmaceuticals Target Price Odds to finish over 1.86
The tendency of Universe Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.86 | 90 days | 1.86 | about 73.96 |
Based on a normal probability distribution, the odds of Universe Pharmaceuticals to move above the current price in 90 days from now is about 73.96 (This Universe Pharmaceuticals probability density function shows the probability of Universe Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Universe Pharmaceuticals has a beta of 0.0463. This usually implies as returns on the market go up, Universe Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Universe Pharmaceuticals will be expected to be much smaller as well. Additionally Universe Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Universe Pharmaceuticals Price Density |
| Price |
Predictive Modules for Universe Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Universe Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Universe Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Universe Pharmaceuticals is not an exception. The market had few large corrections towards the Universe Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Universe Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Universe Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -3.7 | |
β | Beta against Dow Jones | 0.05 | |
σ | Overall volatility | 17.01 | |
Ir | Information ratio | -0.3 |
Universe Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Universe Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Universe Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Universe Pharmaceuticals generated a negative expected return over the last 90 days | |
| Universe Pharmaceuticals has high historical volatility and very poor performance | |
| Universe Pharmaceuticals may become a speculative penny stock | |
| Universe Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 32.31 M. Reported Net Loss for the year was (6.16 M) with profit before taxes, overhead, and interest of 21.89 M. | |
| Latest headline from news.google.com: Universe Pharmaceuticals stock hits 52-week low at 1.78 By Investing.com - Investing.com Australia |
Universe Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Universe Stock often depends not only on the future outlook of the current and potential Universe Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Universe Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.6 M | |
| Cash And Short Term Investments | 18.5 M |
Universe Pharmaceuticals Technical Analysis
Universe Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Universe Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Universe Pharmaceuticals. In general, you should focus on analyzing Universe Stock price patterns and their correlations with different microeconomic environments and drivers.
Universe Pharmaceuticals Predictive Forecast Models
Universe Pharmaceuticals' time-series forecasting models is one of many Universe Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Universe Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Universe Pharmaceuticals
Checking the ongoing alerts about Universe Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Universe Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Universe Pharmaceuticals generated a negative expected return over the last 90 days | |
| Universe Pharmaceuticals has high historical volatility and very poor performance | |
| Universe Pharmaceuticals may become a speculative penny stock | |
| Universe Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 32.31 M. Reported Net Loss for the year was (6.16 M) with profit before taxes, overhead, and interest of 21.89 M. | |
| Latest headline from news.google.com: Universe Pharmaceuticals stock hits 52-week low at 1.78 By Investing.com - Investing.com Australia |
Check out Universe Pharmaceuticals Backtesting, Universe Pharmaceuticals Valuation, Universe Pharmaceuticals Correlation, Universe Pharmaceuticals Hype Analysis, Universe Pharmaceuticals Volatility, Universe Pharmaceuticals History as well as Universe Pharmaceuticals Performance. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share (76.35) | Revenue Per Share 7.351 | Quarterly Revenue Growth (0.30) | Return On Assets (0.06) |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.